Useful Treatment of Severe Atopic Dermatitis with Ganoderma Lucidum: A Multiple-Case Study
Authors: E. B. Walters, M.D., and D. Keeney, M.D.
Journal: Alternative Therapies in Health and Medicine
Study Design:
- Intervention: 900 mg of Ganoderma lucidum (G. lucidum) extract, three times daily
- Participants: 4 patients with severe atopic dermatitis (AD)
- Duration: 8 weeks
- Outcome Measures:
- Severity Scoring of Atopic Dermatitis (SCORAD) index
- Eczema Area and Severity Index (EASI)
- Physician Global Assessment (PGA)
- Patient Global Assessment (PtGA)
Summary: This study examined the effects of Ganoderma lucidum (G. lucidum) extract on severe atopic dermatitis (AD) in four patients. After 8 weeks of treatment, all patients experienced significant improvements in their AD symptoms, as measured by the SCORAD, EASI, PGA, and PtGA. These improvements included reduced itching, redness, dryness, and skin thickening. Additionally, no adverse effects were reported. These findings suggest that G. lucidum may be a safe and effective treatment for AD, but further research is needed to confirm these results.
No responses yet